Multifunctional nanomicellar systems for delivering anticancer drugs

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 6, 2014, Pages 2024-2038

  Chen, Yi Chun ^a,b   Lo, Chun Liang ^c   Hsiue, Ging Ho ^a,b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

cancer therapy; controlled drug delivery; micelles; stimuli responsive; tumor targeting

Indexed keywords

CONTROLLED DRUG DELIVERY; COPOLYMERS; ONCOLOGY; TUMORS;

ACTIVE TARGETING; ANTI-CANCER DRUG DELIVERY; ANTICANCER DRUG; CANCER CELLS; CANCER THERAPY; MICELLAR SYSTEMS; STIMULI-RESPONSIVE; TUMOR TARGETING;

MICELLES;

ANTINEOPLASTIC AGENT; COPOLYMER; DOXORUBICIN; RAPAMYCIN; DELAYED RELEASE FORMULATION; MICELLE; POLYMER;

CANCER CHEMOTHERAPY; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG TARGETING; MICELLE; MULTIFUNCTIONAL MICELLAR SYSTEM; PH; POLYMERIZATION; REVIEW; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HUMAN; NEOPLASMS; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; NEOPLASMS; POLYMERS;

EID: 84899443763     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34850     Document Type: Review

References (126)

1. Hamed S, Barshack I, Luboshits G, Wexler D, Deutsch V, Keren G, George J,. Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy. Eur Heart J 2006; 27: 1876-1883.
2. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B,. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. J Biol Chem 2004; 279: 25535-25543.
3. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB,. Influence of vesicle Size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 1989; 49: 5922-5930.
4. Davis ME, Chen Z, Shin DM,. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771-782.
5. Torchilin VP,. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006; 58: 1532-1555.
6. Owen SC, Chan DPY, Shoichet MS,. Polymeric micelle stability. Nano Today 2012; 7: 53-65.
7. Kabanov AV, Batrakova EV, Alakhov VY,. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002; 82: 189-212.
8. Carstens MG, Bevernage JJL, van Nostrum CF, van Steenbergen MJ, Flesch FM, Verrijk R, de Leede LGJ, Crommelin DJA, Hennink WE,. Small Oligomeric micelles based on end group modified mPEG-oligocaprolactone with monodisperse hydrophobic blocks. Macromolecules 2006; 40: 116-122.
9. Van Domeselaar GH, Kwon GS, Andrew LC, Wishart DS,. Application of solid phase peptide synthesis to engineering PEO-peptide block copolymers for drug delivery. Colloids Surf B Biointerfaces 2003; 30: 323-334.
10. Lee J, Cho EC, Cho K,. Incorporation and release behavior of hydrophobic drug in functionalized poly(D, L -lactide)-block-poly(ethylene oxide) micelles. J Control Release 2004; 94: 323-335.
11. Lo CL, Lin SJ, Tsai HC, Chan WH, Tsai CH, Cheng CHD, Hsiue GH,. Mixed micelle systems formed from critical micelle concentration and temperature-sensitive diblock copolymers for doxorubicin delivery. Biomaterials 2009; 30: 3961-3970.
12. Christie RJ, Matsumoto Y, Miyata K, Nomoto T, Fukushima S, Osada K, Halnaut J, Pittella F, Kim HJ, Nishiyama N, Kataoka, K., Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection. ACS Nano 2012; 6: 5174-5189.
13. Kim SH, Tan JPK, Nederberg F, Fukushima K, Yang YY, Waymouth RM, Hedrick JL,. Mixed micelle formation through stereocomplexation between enantiomeric poly(lactide) block copolymers. Macromolecules 2009; 42: 25-29.
14. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS,. Doxorubicin-loaded poly(ethylene glycol)-poly(β- benzyl- L -aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Release 2000; 64: 143-153.
15. Sumitani S, Nagasaki Y,. Boron neutron capture therapy assisted by boron-conjugated nanoparticles. Polym J 2012; 44: 522-530.
16. Xu X, Flores JD, McCormick CL,. Reversible imine shell cross-linked micelles from aqueous RAFT-synthesized thermoresponsive triblock copolymers as potential nanocarriers for "pH-triggered" drug release. Macromolecules 2011; 44: 1327-1334.
17. Talelli M, Iman M, Varkouhi AK, Rijcken CJF, Schiffelers RM, Etrych T, Ulbrich K, van Nostrum CF, Lammers T, Storm G, Hennink WE,. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials 2010; 31: 7797-7804.
18. Crommelin DJA, Scherphof G, Storm G,. Active targeting with particulate carrier systems in the blood compartment. Adv Drug Deliv Rev 1995; 17: 49-60.
19. Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, Langer R,. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995; 16: 215-233.
20. Papisov MI,. Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. Adv Drug Deliv Rev 1998; 32: 119-138.
21. Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC,. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008; 33: 113-137.
22. Talelli M, Rijcken CJF, van Nostrum CF, Storm G, Hennink WE,. Micelles based on HPMA copolymers. Adv Drug Deliv Rev 2010; 62: 231-239.
23. Morille M, Montier T, Legras P, Carmoy N, Brodin P, Pitard B, Benoît JP, Passirani C,. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 2010; 31: 321-329.
24. Vonarbourg A, Passirani C, Saulnier P, Benoit JP,. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006; 27: 4356-4373.
25. Torchilin VP,. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv Drug Deliv Rev 2005; 57: 95-109.
26. Huang CK, Lo CL, Chen H-H, Hsiue GH,. Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater 2007; 17: 2291-2297.
27. Hans M, Shimoni K, Danino D, Siegel SJ, Lowman A,. Synthesis and characterization of mPEG-PLA prodrug micelles. Biomacromolecules 2005; 6: 2708-2717.
28. Dong Y, Feng SS,. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004; 25: 2843-2849.
29. Lo CL, Huang CK, Lin KM, Hsiue GH,. Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery. Biomaterials 2007; 28: 1225-1235.
30. Tsai HC, Chang WH, Lo CL, Tsai CH, Chang CH, Ou TW, Yen TC, Hsiue GH,. Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials 2010; 31: 2293-2301.
31. Soga O, van Nostrum CF, Fens M, Rijcken CJF, Schiffelers RM, Storm G, Hennink WE,. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 2005; 103: 341-353.
32. Lo CL, Lin KM, Huang CK, Hsiue GH,. Self-assembly of a micelle structure from graft and diblock copolymers: An example of overcoming the limitations of polyions in drug delivery. Adv Funct Mater 2006; 16: 2309-2316.
33. Danhier F, Feron O, Préat V,. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010; 148: 135-146.
34. Maeda H,. Tumor-selective delivery of macromolecular drugs via the EPR Effect: Background and future Prospects. Bioconjug Chem 2010; 21: 797-802.
35. Fang J, Nakamura H, Maeda H,. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63: 136-151.
36. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK,. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998; 95: 4607-4612.
37. Kerbel RS,. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-2049.
38. Skinner SA, Tutton PJM, O'Brien PE,. Microvascular architecture of experimental colon tumors in the rat. Cancer Res 1990; 50: 2411-2417.
39. Daruwalla J, Nikfarjam M, Greish K, Malcontenti-Wilson C, Muralidharan V, Christophi C, Maeda H,. In vitro and in vivo evaluation of tumor targeting SMA-pirarubicin micelles: Survival improvement and inhibition of liver metastases. Cancer Sci 2010; 101: 1866-1874.
40. Greish K, Nagamitsu A, Fang J, Maeda H,. Copoly(styrene-maleic acid)-pirarubicin micelles: High tumor-targeting efficiency with little toxicity. Bioconjug Chem 2004; 16: 230-236.
41. Allen TM,. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750-763.
42. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM,. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006; 5: 219-234.
43. Ross JF, Chaudhuri PK, Ratnam M,. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994; 73: 2432-2443.
44. Bae Y, Nishiyama N, Kataoka K,. In Vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 2007; 18: 1131-1139.
45. Lu PL, Chen YC, Ou TW, Chen HH, Tsai HC, Wen CJ, Lo CL, Wey SP, Lin KJ, Yen TC, Hsiue GH,. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials 2011; 32: 2213-2221.
46. Schwartz AL, Bolognesi A, Fridovich SE,. Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells. J Cell Biol 1984; 98: 732-738.
47. Yang R, Meng F, Ma S, Huang F, Liu H, Zhong Z,. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Biomacromolecules 2011; 12: 3047-3055.
48. Yamano S, Dai J, Yuvienco C, Khapli S, Moursi AM, Montclare JK,. Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis. J Control Release 2011; 152: 278-285.
49. Sethuraman VA, Bae YH,. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 2007; 118: 216-224.
50. Brannon-Peppas L, Blanchette JO,. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004; 56: 1649-1659.
51. Shi M, Ho K, Keating A, Shoichet MS,. Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery. Adv Funct Mater 2009; 19: 1689-1696.
52. Kumari A, Yadav SK, Yadav SC,. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010; 75: 1-18.
53. Tian H, Tang Z, Zhuang X, Chen X, Jing X,. Biodegradable synthetic polymers: Preparation, functionalization and biomedical application. Prog Polym Sci 2012; 37: 237-280.
54. Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R,. Biodegradable long-circulating polymeric nanospheres. Science 1994; 263: 1600-1603.
55. Sun H, Guo B, Cheng R, Meng F, Liu H, Zhong Z,. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 2009; 30: 6358-6366.
56. Dong Y, Feng SS,. Nanoparticles of poly(D, L -lactide)/methoxy poly(ethylene glycol)-poly(D, L -lactide) blends for controlled release of paclitaxel. J Biomed Mater Res A 2006; 78: 12-19.
57. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE,. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release 2006; 116: 150-158.
58. Discher DE, Ahmed F,. Polymersomes. Annu Rev Biomed Eng 2006; 8: 323-341.
59. Yasugi K, Nagasaki Y, Kato M, Kataoka K,. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D, L -lactide) block copolymers as potential drug carrier. J Control Release 1999; 62: 89-100.
60. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K,. Long-circulating poly(ethylene glycol)-poly(D, L -lactide) block copolymer micelles with modulated surface charge. J Control Release 2001; 77: 27-38.
61. Shin HC, Alani AWG, Rao DA, Rockich NC, Kwon GS,. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J Control Release 2009; 140: 294-300.
62. Agrawal CM, Ray RB,. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001; 55: 141-150.
63. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC,. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007; 28: 869-876.
64. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R,. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 2006; 103: 6315-6320.
65. Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V,. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Control Release 2009; 133: 11-17.
66. Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H,. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011; 32: 8010-8020.
67. Forrest ML, Won CY, Malick AW, Kwon GS,. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(-caprolactone) micelles. J Control Release 2006; 110: 370-377.
68. Park EK, Kim SY, Lee SB, Lee YM,. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 2005; 109: 158-168.
69. Simamora P, Alvarez JM, Yalkowsky SH,. Solubilization of rapamycin. Int J Pharm 2001; 213: 25-29.
70. Yáñez J, Forrest M, Ohgami Y, Kwon G, Davies N,. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(ε- caprolactone) micelles of rapamycin. Cancer Chemother Pharmacol 2008; 61: 133-144.
71. Tannock IF, Rotin D,. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989; 49: 4373-4384.
72. Gerweck LE, Vijayappa S, Kozin S,. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 2006; 5: 1275-1279.
73. Dirk S,. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 2006; 58: 1655-1670.
74. Hubbell JA,. Enhancing drug function. Science 2003; 300: 595-596.
75. Li YL, Zhu L, Liu Z, Cheng R, Meng F, Cui J-H, Ji S-J, Zhong Z,. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed Eng 2009; 48: 9914-9918.
76. Chen YC, Liao LC, Lu PL, Lo CL, Tsai HC, Huang CY, Wei KC, Yen TC, Hsiue GH,. The accumulation of dual pH and temperature responsive micelles in tumors. Biomaterials 2012; 33: 4576-4588.
77. Lee ES, Na K, Bae YH,. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 2005; 103: 405-418.
78. Lee ES, Na K, Bae YH,. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005; 5: 325-329.
79. Kim D, Lee ES, Oh KT, Gao ZG, Bae YH,. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. Small 2008; 4: 2043-2050.
80. Johnson RP, Jeong YI, Choi E, Chung CW, Kang DH, Oh SO, Suh H, Kim I,. Biocompatible poly(2-hydroxyethyl methacrylate)-b-poly(L -histidine) hybrid materials for pH-sensitive intracellular anticancer drug delivery. Adv Funct Mater 2011; 22: 1058-1068.
81. Lin SY, Hsu WH, Lo JM, Tsai HC, Hsiue GH,. Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery. J Control Release 2011; 154 (1): 84-92.
82. Tsai HC, Chang CH, Chiu YC, Lin SY, Lin CP, Hsiue GH,. In vitro evaluation of hexagonal polymeric micelles in macrophage phagocytosis. Macromol Rapid Commun 2011; 32: 1442-1446.
83. Tsai HC, Tsai CH, Lin SY, Jhang CR, Chiang YS, Hsiue GH,. Stimulated release of photosensitizers from graft and diblock micelles for photodynamic therapy. Biomaterials 2012; 33: 1827-1837.
84. Hsiue GH, Wang CH, Lo CL, Wang CH, Li JP, Yang JL,. Environmental- sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(L -lactide) diblock copolymer for application in drug delivery. Int J Pharm 2006; 317: 69-75.
85. Wang CH, Wang CH, Hsiue GH,. Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J Control Release 2005; 108: 140-149.
86. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K,. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2004; 16: 122-130.
87. Hrubý M, Koňák Č, Ulbrich K,. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Release 2005; 103: 137-148.
88. Alani AWG, Bae Y, Rao DA, Kwon GS,. Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel. Biomaterials 2010; 31: 1765-1772.
89. Lee S, Saito K, Lee HR, Lee MJ, Shibasaki Y, Oishi Y, Kim BS,. Hyperbranched double hydrophilic block copolymer micelles of poly(ethylene oxide) and polyglycerol for pH-responsive drug delivery. Biomacromolecules 2012; 13: 1190-1196.
90. Binauld S, Scarano W, Stenzel MH,. pH-triggered release of platinum drugs conjugated to micelles via an acid-cleavable linker. Macromolecules 2012; 45: 6989-6999.
91. Stefanadis C, Chrysochoou C, Markou D, Petraki K, Panagiotakos DB, Fasoulakis C, Kyriakidis A, Papadimitriou C, Toutouzas PK,. Increased temperature of malignant urinary bladder tumors in vivo: The application of a new method based on a catheter technique. J Clin Oncol 2001; 19: 676-681.
92. Chung JE, Yokoyama M, Aoyagi T, Sakurai Y, Okano T,. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers. J Control Release 1998; 53: 119-130.
93. Chung JE, Yokoyama M, Aoyagi T, Sakurai Y, Okano T,. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers. J Control Release 1998; 53: 119-130.
94. Neradovic D, van Nostrum CF, Hennink WE,. Thermoresponsive polymeric micelles with controlled instability based on hydrolytically sensitive N-isopropylacrylamide copolymers. Macromolecules 2001; 34: 7589-7591.
95. Dai S, Ravi P, Tam KC,. Thermo- and photo-responsive polymeric systems. Soft Matter 2009; 5: 2513-2533.
96. Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M,. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release 2006; 115: 46-56.
97. Kohori F, Sakai K, Aoyagi T, Yokoyama M, Yamato M, Sakurai Y, Okano T,. Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b- poly(D, L -lactide). Colloids Surf B Biointerfaces 1999; 16: 195-205.
98. Neradovic D, van Steenbergen MJ, Vansteelant L, Meijer YJ, van Nostrum CF, Hennink WE,. Degradation mechanism and kinetics of thermosensitive polyacrylamides containing lactic acid side chains. Macromolecules 2003; 36: 7491-7498.
99. Neradovic D, Soga O, Van Nostrum CF, Hennink WE,. The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials 2004; 25: 2409-2418.
100. Soga O, van Nostrum CF, Hennink WE,. Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): A new class of biodegradable polymers with tuneable thermosensitivity. Biomacromolecules 2004; 5: 818-821.
101. Soga O, van Nostrum CF, Ramzi A, Visser T, Soulimani F, Frederik PM, Bomans PHH, Hennink WE,. Physicochemical characterization of degradable thermosensitive polymeric micelles. Langmuir 2004; 20: 9388-9395.
102. Rijcken CJF, Hofman JW, van Zeeland F, Hennink WE, van Nostrum CF,. Photosensitiser-loaded biodegradable polymeric micelles: Preparation, characterisation and in vitro PDT efficacy. J Control Release 2007; 124: 144-153.
103. Talelli M, Rijcken CJF, Lammers T, Seevinck PR, Storm G, van Nostrum CF, Hennink WE,. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: Toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 2009; 25: 2060-2067.
104. Schilli CM, Zhang M, Rizzardo E, Thang SH, Chong YK, Edwards K, Karlsson G, Müller AHE,. A new double-responsive block copolymer synthesized via RAFT polymerization: Poly(N-isopropylacrylamide)-block-poly(acrylic acid). Macromolecules 2004; 37: 7861-7866.
105. Soppimath KS, Tan DCW, Yang YY,. pH-Triggered Thermally Responsive Polymer core-shell nanoparticles for drug delivery. Adv Mater 2005; 17: 318-323.
106. Xu Y, Shi L, Ma R, Zhang W, An Y, Zhu XX,. Synthesis and micellization of thermo- and pH-responsive block copolymer of poly(N-isopropylacrylamide)-block- poly(4-vinylpyridine). Polymer 2007; 48: 1711-1717.
107. Zhang L, Guo R, Yang M, Jiang X, Liu B,. Thermo and pH dual-responsive nanoparticles for anti-cancer drug delivery. Adv Mater 2007; 19: 2988-2992.
108. Li G, Shi L, An Y, Zhang W, Ma R,. Double-responsive core-shell-corona micelles from self-assembly of diblock copolymer of poly(t-butyl acrylate-co-acrylic acid)-b-poly(N-isopropylacrylamide). Polymer 2006; 47: 4581-4587.
109. Chen YC, Lo CL, Lin YF, Hsiue GH,. Rapamycin encapsulated in dual-responsive micelles for cancer therapy. Biomaterials 2013; 34: 1115-1127.
110. Konak C, Kopeckova P, Kopecek J,. Photoregulated association of N-(2-hydroxypropyl)methacrylamide copolymers with azobenzene-containing side chains. Macromolecules 1992; 25: 5451-5456.
111. Wang G, Tong X, Zhao Y,. Preparation of azobenzene-containing amphiphilic diblock copolymers for light-responsive micellar aggregates. Macromolecules 2004; 37: 8911-8917.
112. Zhao Y, He J,. Azobenzene-containing block copolymers: The interplay of light and morphology enables new functions. Soft Matter 2009; 5: 2686-2693.
113. Wang Y, Hong CY, Pan CY,. Spiropyran-based hyperbranched star copolymer: Synthesis, phototropy, FRET, and bioapplication. Biomacromolecules 2012; 13: 2585-2593.
114. Chen J, Zeng F, Wu S, Zhao J, Chen Q, Tong Z,. Reversible fluorescence modulation through energy transfer with ABC triblock copolymer micelles as scaffolds. Chem Commun 2008: 5580-5582.
115. Chatterjee DK, Fong LS, Zhang Y,. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv Drug Deliv Rev 2008; 60: 1627-1637.
116. Jang WD, Nishiyama N, Zhang GD, Harada A, Jiang DL, Kawauchi S, Morimoto Y, Kikuchi M, Koyama H, Aida T, Kataoka K,. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angew Chem Int Ed Engl 2005; 117: 423-427.
117. Wu DQ, Li ZY, Li C, Fan JJ, Lu B, Chang C, Cheng SX, Zhang XZ, Zhuo RX,. Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy. Pharm Res 2010; 27: 187-199.
118. Rapoport N, Pitt WG, Sun H, Nelson JL,. Drug delivery in polymeric micelles: From in vitro to in vivo. J Controlled Release 2003; 91: 85-95.
119. Husseini GA, Myrup GD, Pitt WG, Christensen DA, Rapoport NY,. Factors affecting acoustically triggered release of drugs from polymeric micelles. J Control Release 2000; 69: 43-52.
120. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA, Rapoport NY,. Drug delivery in pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release 2002; 84: 39-47.
121. Mohan P, Rapoport N,. Doxorubicin as a molecular nanotheranostic agent: Effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm 2010; 7: 1959-1973.
122. Tung S, Jackson J, Burt H, Mu C,. Drug uptake enhancement using sonodynamic effects at 4 MHz-A potential application for micro-ultrasonic- transducers. IEEE Trans Biomed Eng 2007; 54: 1153-1156.
123. Jackson JK, Pirmoradi FN, Wan CPL, Siu T, Chiao M, Burt HM,. Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics 2011; 51: 932-939.
124. Kim D, Gao ZG, Lee ES, Bae YH,. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm 2009; 6: 1353-1362.
125. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin SF, Sherry AD, Boothman DA, Gao J,. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006; 6: 2427-2430.
126. Khemtong C, Kessinger CW, Ren J, Bey EA, Yang SG, Guthi JS, Boothman DA, Sherry AD, Gao J,. In vivo off-resonance saturation magnetic resonance imaging of αvβ3-targeted superparamagnetic nanoparticles. Cancer Res 2009; 69: 1651-1658.